Bernard Ponsard

Person

Ponsard, Bernard

  • Belgian Reactor 2

Person: Employee

  1. 2020
  2. Large-scale production of lutetium-177m for the 177mLu/177Lu radionuclide generator

    Bhardwaj, R., Ponsard, B., Sarilar, M., Wolterbeek, H. T., Denkova, A. & Serra-Crespo, P., Feb 2020, In : Applied Radiation and Isotopes. 156, 108986.

    Research output: Contribution to journalArticle

  3. 2019
  4. Therapeutic Potential of 47Sc in Comparison to 177Lu and 90Y: Preclinical Investigations

    Siwowska, K., Guzik, P., Domnanich, K. A., Monné Rodriguez, J. M., Bernhardt, P., Ponsard, B., Hasler, R., Borgna, F., Schibli, R., Köster, U., van der Meulen, N. P. & Müller, C., 20 Aug 2019, In : Pharmaceutics. 11, 8, p. 1-13 13 p.

    Research output: Contribution to journalArticle

  5. 2017
  6. Determination of impurity distributions in ingots of solar grade silicon by neutron activation analysis

    Karches, B., Schön, J., Gerstenberg, H., Hampel, G., Krenckel, P., Plonka, C., Ponsard, B., Riepe, S., Stieghorst, C. & Wiehl, N., 1 Oct 2017, In : Radiochimica Acta. 105, 7, p. 569-576 8 p.

    Research output: Contribution to journalArticle

  7. 2016
  8. Labeling and preliminary in vivo assessment of niobium-labeled radioactive species: A proof-of-concept study

    Ponsard, B., Radchenko, V., Bouziotis, P., Tsotakos, T., Paravatou-Petsotas, M., de la Fuente, A., Loudos, G., Harris, A. L., Xanthopoulos, S., Filosofov, D., Hauser, H., Eisenhut, M. & Roesch, F., 1 May 2016, In : Nuclear Medicine and Biology. 43, 5, p. 280-287 8 p.

    Research output: Contribution to journalArticle

  9. Current Status and Future of Mo-99 Supply

    Ponsard, B., 1 Jan 2016, In : ATW- International Journal of Nuclear Power. 61, 1, p. 41-44 4 p.

    Research output: Contribution to journalArticle

  10. 2014
  11. Biological Carrier Molecules of Radiopharmaceuticals for Molecular Cancer Imaging and Targeted Cancer Therapy

    Aerts, A., Impens, N., Gijs, M., D'huyvetter, M., Vanmarcke, H., Ponsard, B., Lahoutte, T., Luxen, A., Baatout, S. & Hardeman, F., Oct 2014, In : Current Pharmaceutical Design. 20, 32, p. 5218-5244

    Research output: Contribution to journalArticle

  12. 2013
  13. The necessity of nuclear reactors for targeted radionuclide therapies

    Krijger, G., Ponsard, B., Harfensteller, M., Wolterbeek, H. & Nijsen, J., Jul 2013, In : Trends in Biotechnology. 31, 7, p. 390-396

    Research output: Contribution to journalArticle

  14. 2012
  15. Development of 177Lu-nanobodies for radioimmunotherapy of HER2-positive breast cancer: evaluation of different bifunctional chelators

    D'huyvetter, M., Aerts, A., Xavier, C., Vaneycken, I., Devoogdt, N., Gijs, M., Impens, N., Baatout, S., Ponsard, B., Muyldermans, S., Caveliers, V. & Lahoutte, T., Apr 2012, In : Contrast Media & Molecular Imaging. 7, 2, p. 254-264

    Research output: Contribution to journalArticle

  16. 2009
  17. Production of Sn-117m in the BR2 high-flux reactor

    Ponsard, B., Srivastava, S. C., Mausner, L. F., Knapp, R. F. F., Garland, M. A. & Mirzadeh, S., 1 Jul 2009, In : Applied Radiation and Isotopes. 67, 7-8, p. 1158-1161 4 p.

    Research output: Contribution to journalArticle

  18. 2008
  19. Medical-isotope supply hit by production problems

    Ponsard, B. & Gould, P., Oct 2008, In : Physics World. 21, 10, p. 12-12

    Research output: Contribution to journalArticle

Previous 1 2 Next

ID: 31181